Beeline:GRIN相关神经发育障碍的3期研究
一项国际多中心研究,包括开放标签的1b期和随机、双盲、安慰剂对照的3期阶段,随后进行开放标签扩展,旨在评估Radiprodil在GRIN相关神经发育障碍参与者中的疗效、安全性、耐受性及药代动力学
The Phase 3 portion of Study RAD-GRIN-101 is a multinational, multicenter, randomized, double-blind, placebo-controlled trial followed by an open-label extension to evaluate the efficacy and safety of radiprodil in participants with GRIN-related neurodevelopmental disorder (GRIN-NDD) with a gain-of-function (GoF) genetic variant.
This study will enroll two cohorts: one cohort of participants with a minimal number of countable motor seizures (with or without behavioral symptoms) (Phase 3 Cohort 1: Qualifying Seizures Cohort); and a second cohort with disease symptoms but no seizures or fewer seizures than required for the Qualifying Seizures Cohort (Phase 3 Cohort 2: Without Qualifying Seizures Auxiliary Cohort).
Participants in each cohort will be randomized 1:1 to receive active drug (radiprodil) or matching placebo (Part A). Following completion of Part A, all eligible participants (including those previously on placebo) may continue into the open-label extension period (Part B) to receive radiprodil.
The placebo-controlled portion is expected to be approximately 16 weeks for participants in Phase 3 Cohort 1 and 28 weeks for participants in Phase 3 Cohort 2.
The study will evaluate the effect of radiprodil on seizures and non-seizure symptoms and assess safety.
研究概览
详细说明
Participants are assigned in a 1:1 ratio to receive either radiprodil or placebo during Part A with the opportunity to receive radiprodil in the Open-Label Extension, Part B. The dosing regimen includes a fixed titration schedule over 4 weeks.
This study is divided into the following parts:
Part A: Randomized, double-blind, placebo-controlled
- Screening/Observation Period: To assess eligibility
- Titration Period (approximately 4 weeks): Titration of radiprodil or placebo to target dose
- Maintenance Period (Part A): Target dose of radiprodil or placebo maintained for 12 weeks (Phase 3 Cohort 1) or 24 weeks (Phase 3 Cohort 2)
- Tapering and Follow-up Period: Gradual decrease and Follow-up Period for participants not entering Part B
Part B: Open-label safety follow-up period
- Open-Label Treatment Period: Participants will continue to receive radiprodil until such time as either the participant withdraws/is withdrawn from the study, sponsor terminates the study, or market access is available
- Tapering and Follow-up Period: Gradual decrease and follow-up observation period for participants upon leaving the study
研究类型
注册 (估计的)
阶段
- 第三阶段
联系人和位置
学习联系方式
- 姓名:Clinical Operations
- 电话号码:+1-877-225-0014
- 邮箱:ClinicalTrials@GrinTherapeutics.com
学习地点
-
-
-
Bielefeld、德国、33617
- 招聘中
- Universitatsklinikum OWL der Universitat Bielefeld
-
首席研究员:
- Tilman Polster, MD
-
Greifswald、德国
- 招聘中
- Universitatsmedizin Greifswald Klinik und Poliklinik fur Frauenheilkunde und Geburtshilfe
-
接触:
- Astrid Bertsche
- 邮箱:astrid.bertsche@med.uni-greifswald.de
-
首席研究员:
- Astrid Bertsche
-
Leipzig、德国、04103
- 招聘中
- Klinik und Policlinik fur Kinder - und Jugendmedizin
-
接触:
- Andreas Merkenschlager
- 邮箱:Andreas.Merkenschlager@medizin.uni-leipzig.de
-
首席研究员:
- Andreas Merkenschlager
-
-
Saxony
-
Leipzig、Saxony、德国、04103
- 招聘中
- Universitatsklinikum Leipzig
-
首席研究员:
- Andreas Merkenschlager, MD
-
-
-
-
-
Bologna、意大利、40139
- 招聘中
- Azienda Unita Sanitaria Locale Di Bologna, IRCCS lstituto Delle Scienze Neurologiche
-
首席研究员:
- Luca Soliani Soliani, MD
-
Milan、意大利、20133
- 招聘中
- Fondazione IRCCS lstituto Neurologico Carlo Besta
-
首席研究员:
- Francesca Ragona, MD
-
Pavia、意大利
- 招聘中
- IRCCS Fondazione Istituto Neurologico Nazionale Casimiro Mondino
-
首席研究员:
- Valentina De Giorgis
-
接触:
- Valentina De Giorgis
- 邮箱:valentina.degiorgis@mondino.it
-
Pavia、意大利、27100
- 招聘中
- Fondazione lstituto Neurologico Nazionale Casimiro Mondino
-
接触:
- MD, PhD
-
首席研究员:
- Valentina De Giorgis, MD, PhD
-
Roma、意大利、00165
- 招聘中
- Ospedale Pediatrico Bambino Gesu
-
首席研究员:
- Nicola Specchio
-
接触:
- Nicola Specchio
- 邮箱:nicola.specchio@opbg.net
-
接触:
- Nicola Pietrafusa
- 邮箱:nicola1.pietrafusa@opbg.net
-
副研究员:
- Nicola Pietrafusa
-
-
Viale Pieraccini
-
Florence、Viale Pieraccini、意大利、24
- 招聘中
- Azienda Ospedaliera Universitaria Meyer IRCCS
-
首席研究员:
- Renzo Guerrini
-
接触:
- Renzo Guerrini
- 邮箱:r.guerrini@meyer.it
-
-
-
-
-
Ljubljana、斯洛文尼亚、1525
- 招聘中
- University Children's Hospital
-
首席研究员:
- Damjan Osredkar
-
接触:
- Damjan Osredkar
- 邮箱:damjan.osredkar@kclj.si
-
接触:
- Nika Košir
- 邮箱:nika.kosir@kclj.si
-
-
-
-
-
Minami、日本
- 招聘中
- Kanagawa Children's Medical Center
-
首席研究员:
- Tomohide Goto, MD
-
Miyazaki、日本
- 招聘中
- University of Miyazaki Hospital
-
首席研究员:
- Yasuhiro Kimoto, MD
-
Nagoya、日本
- 招聘中
- Nagoya University Hospital
-
首席研究员:
- Hiroyuki Kidokoro, MD
-
Niigata、日本
- 招聘中
- National Hospital Organization Nishiniigata Chuo Hospital
-
首席研究员:
- Yu Kobayashi, MD
-
Osaka、日本、534-0021
- 招聘中
- Local Incorporated Administrative Agency Osaka City Hospital Organization Osaka City General Hospital
-
首席研究员:
- Shin Okazaki, MD
-
Shibukawa、日本
- 招聘中
- Showa Medical University Hospital
-
首席研究员:
- Mitsuhiro Kato, MD
-
-
-
-
-
Brussels、比利时、1090
- 招聘中
- UZ Brussel
-
接触:
- Ine Hoogwijs
- 邮箱:ine.hoogwijs@uzbrussel.be
-
接触:
- Yentse Caeyers
- 邮箱:yentse.caeyers@uzbrussel.be
-
首席研究员:
- Ine Hoogwijs
-
Edegem、比利时、2650
- 招聘中
- University Hospital Antwerp
-
首席研究员:
- Matthias de Wachter, MD
-
-
-
-
-
Angers、法国、49933
- 招聘中
- CHU Angers
-
首席研究员:
- Patrick van Bogaert, MD
-
Angers、法国、49933
- 招聘中
- Centre Hospitalier Universitaire d'Angers (CHU Angers)
-
接触:
- Patrick Van Bogaert
- 邮箱:Patrick.VanBogaert@chu-angers.fr
-
首席研究员:
- Patrick Van Bogaert
-
Bron、法国、69500
- 招聘中
- Hospices Civils de Lyon
-
首席研究员:
- Eleni Panagiotakaki, MD, PhD
-
Bron、法国、69677
- 招聘中
- Hospices Civils De Lyon
-
接触:
- Eleni Panagiotakaki
- 邮箱:eleni.panagiotakaki@chu-lyon.fr
-
接触:
- Lea Barbieri
- 邮箱:lea.barbieri01@chu-lyon.fr
-
首席研究员:
- Eleni Panagiotakaki
-
Dijon、法国、21079
- 招聘中
- CHU de Dijon
-
首席研究员:
- Benoit Mazel, MD
-
Marseille、法国、13005
- 招聘中
- AP HM Hopital d'enfants de la Timone
-
首席研究员:
- Mathieu Milh, MD, PhD
-
Paris、法国、75015
- 招聘中
- Hopital Necker Enfants Malades (APHP)
-
首席研究员:
- Rima El Nabbout, MD, PhD
-
Paris、法国、75743
- 招聘中
- Hôpital Necker Enfants Malades
-
接触:
- Michaela Semeraro
- 邮箱:michaela.semeraro@aphp.fr
-
接触:
- Rima Nabbout
- 邮箱:rima.nabbout@aphp.fr
-
首席研究员:
- Rima Nabbout
-
Toulouse、法国、31059
- 招聘中
- Hopital des Enfants ; CHU Toulouse
-
首席研究员:
- Caroline Hachon Le Camus, MD
-
Toulouse、法国、Cedex 9
- 招聘中
- CHU Toulouse - Hôpital Purpan
-
接触:
- Caroline Hachon Le Camus
- 邮箱:hachonlecamus.c@chu-toulouse.fr
-
首席研究员:
- Caroline Hachon Le Camus
-
-
-
-
-
Lodz、波兰、93-338
- 招聘中
- Institute of Polish Mother's Health Center (Instytut Centrum Zdrowia Matki Polki)
-
首席研究员:
- Lukasz Przyslo
-
接触:
- Lukasz Przyslo
- 邮箱:lukasz.przyslo@iczmp.edu.pl
-
-
Masovian Voivodeship
-
Warsaw、Masovian Voivodeship、波兰、04-730
- 招聘中
- lnstytut Pomnik Centrum Zrowia Dziecka
-
首席研究员:
- Sergiusz Jozwiak, MD, PhD
-
-
-
-
Queensland
-
South Brisbane、Queensland、澳大利亚、4101
- 招聘中
- Queensland Children's Hospital
-
首席研究员:
- Catherine Riney
-
-
Victoria
-
Heidelberg、Victoria、澳大利亚、3084
- 招聘中
- Austin Health
-
首席研究员:
- Ingrid Scheffer
-
-
-
-
California
-
Los Angeles、California、美国、90095
- 招聘中
- UCLA Health - Ronald Reagan UCLA Medical Center
-
接触:
- Angela Martinez
- 电话号码:310-968-8942
- 邮箱:AngelaMartinez@mednet.ucla.edu
-
Palo Alto、California、美国、94304
- 招聘中
- Lucile Packard Children's Hospital
-
接触:
- 电话号码:650-721-1458
-
-
Colorado
-
Aurora、Colorado、美国、80045
- 招聘中
- Children's Hospital Colorado - Anschutz Medical Campus
-
-
District of Columbia
-
Washington D.C.、District of Columbia、美国、20010
- 招聘中
- Children's National Medical Center
-
首席研究员:
- John Schreiber, MD
-
Washington D.C.、District of Columbia、美国、20010
- 招聘中
- Children's National Hospital
-
接触:
- Chloe Hooker
- 电话号码:202-476-4809
- 邮箱:chooker@childrensnational.org
-
-
Florida
-
Miami、Florida、美国、33155
- 招聘中
- Nicklaus Children's Hospital
-
接触:
- Dainelys Pena Rodriquez
- 电话号码:786-624-3547
- 邮箱:dainelys.penarodriguez@nicklaushealth.org
-
Winter Park、Florida、美国、32789
- 招聘中
- Pediatric Neurology and Epilepsy
-
接触:
- Denise Hubert
- 电话号码:407-293-1122
- 邮箱:dhubert@pediatricneurologyandepilepsy.com
-
-
Iowa
-
Iowa City、Iowa、美国、52242
- 招聘中
- Iowa Health Care - Pediatric Neurology & Specialty Clinic
-
-
Massachusetts
-
Boston、Massachusetts、美国、02115
- 招聘中
- Boston Children's Hospital
-
接触:
- Helen Olson
- 邮箱:Helen.Olson@childrens.harvard.edu
-
-
New Jersey
-
Hackensack、New Jersey、美国、07601
- 招聘中
- Northeast Regional Epilepsy Group (NEREG) - Hackensack
-
接触:
- Hardik A Rana, MBBS
- 电话号码:551-497-5000
- 邮箱:hrana@epilepsygroup.com
-
-
New York
-
New York、New York、美国、10032
- 招聘中
- Columbia University - Harkness
-
接触:
- Jaimie Gowatsky
- 电话号码:917-838-6514
- 邮箱:jg2917@cumc.columbia.edu
-
-
North Carolina
-
Durham、North Carolina、美国、27710
- 招聘中
- Duke University Health System
-
首席研究员:
- Muhammad Zafar, MD
-
Durham、North Carolina、美国、27705
- 招聘中
- Duke Health-Duke Children's Hospital & Health Center
-
接触:
- Gloria Pinero
- 电话号码:919-613-0767
- 邮箱:gloria.pinero@duke.edu
-
-
Ohio
-
Cincinnati、Ohio、美国、45229
- 招聘中
- Cincinnati Children's Hospital Medical Center
-
首席研究员:
- Kelly Kremer, MD
-
Cincinnati、Ohio、美国、45229
- 尚未招聘
- Cincinnati Children's Hospital Medical Center
-
-
Pennsylvania
-
Philadelphia、Pennsylvania、美国、19104
- 招聘中
- Children's Hospital of Philadelphia
-
接触:
- Jennie Minnick
- 邮箱:MINNICK@chop.edu
-
-
Texas
-
Austin、Texas、美国、78757
- 招聘中
- Child Neurology Consultants of Austin - South Austin
-
Dallas、Texas、美国、75390
- 招聘中
- The University of Texas Southwestern Medical Center (UTSW)
-
Dallas、Texas、美国、75207
- 招聘中
- Children's Health Specialty Center, Dallas
-
首席研究员:
- Charuta Joshi, MD
-
Houston、Texas、美国、77030
- 招聘中
- UTHealth Houston
-
接触:
- Annette Frenk, MSc
- 电话号码:713-500-7164
- 邮箱:Annette.C.FrenkOquendo@uth.tmc.edu
-
-
Washington
-
Seattle、Washington、美国、98105
- 招聘中
- Seattle Children's Hospital
-
-
-
-
-
Glasgow、英国
- 招聘中
- Royal Hospital for Children Glasgow
-
首席研究员:
- Sameer Zuberi
-
接触:
- Sameer Zuberi
- 邮箱:sameer.zuberi@ggc.scot.nhs.uk
-
London、英国、G51 4TF
- 招聘中
- Great Ormond Street Hospital For Children NHS Foundation Trust
-
接触:
- Amy McTague, MD
- 邮箱:a.mctague@ucl.ac.uk
-
首席研究员:
- Amy McTague, MD
-
London、英国、Wc1N 3JH
- 招聘中
- Great Ormond Street Hospital for Children NHS Foundation
-
首席研究员:
- Amy McTague, MBChB, MRCPCH, PhD
-
-
South Yorkshire
-
Sheffield、South Yorkshire、英国
- 招聘中
- Sheffield Children's Hospital NHS Foundation Trust
-
接触:
- Archana Desurkar
- 邮箱:archana.desurkar@sch.nhs.uk
-
首席研究员:
- Archana Desurkar
-
-
-
-
South Holland
-
Rotterdam、South Holland、荷兰
- 招聘中
- Erasmus MC (Erasmus Universitair Medisch Centrum Rotterdam)
-
接触:
- Danielle Veenma
- 邮箱:d.veenma@erasmusmc.nl
-
接触:
-
首席研究员:
- Danielle Veenma
-
副研究员:
- Suzanna Koudijs
-
-
-
-
-
Madrid、西班牙、28009
- 招聘中
- Hospital Universitario Infantil Nino Jesus
-
首席研究员:
- Victor Soto Insuga, MD
-
-
Barcelona
-
Esplugues de Llobregat、Barcelona、西班牙
- 招聘中
- Hospital Sant Joan de Deus
-
首席研究员:
- Angeles Garcia Cazorla
-
接触:
- Angeles Garcia Cazorla
- 邮箱:angeles.garcia@sjd.es
-
接触:
- Juan Lascano Nazareno
- 邮箱:nazarenojuan.lascano@sjd.es
-
副研究员:
- Juan Lascano Nazareno
-
-
-
-
-
Seoul、韩国、03080
- 招聘中
- Seoul National University Hospital
-
首席研究员:
- Jong-Hee Chae, MD, PhD
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
Part A, Participant:
- Diagnosed with GRIN-NDD with GRIN1, GRIN2A, GRIN2B, or GRIN2D gene variants known to result in GoF of the NMDA receptor
- Phase 3 Cohort 1 (Qualifying Seizures Cohort) ONLY: Experiencing at least 1 CMS per week and ≥4 CMS (generalized or focal) during screening
- With history of inadequate response to at least 2 standard antiseizure medications (ASMs)
- Phase 3 Cohort 2 (Without Qualifying Seizures Auxiliary Cohort) ONLY: With significant neurodevelopmental symptoms and a GRIN-CGI-S score ≥4
- On a stable dose of standard ASMs for at least 4 weeks prior to screening and should remain on stable doses throughout study participation
- On stable nonpharmacological treatments such as ketogenic diet and should remain stable throughout study participation
Part B:
- Participant has completed Part A and is eligible to continue study participation according to the judgement of the investigator and sponsor.
Exclusion Criteria:
PART A, Participant:
- Has clinically relevant medical, neurologic, or psychiatric condition and/or behavioral disorder (including those related to GRIN-NDD) that would preclude or jeopardize participant's safe participation or study drug administration or the conduct of the study according to the judgement of the investigator or sponsor.
- Is receiving >4 standard ASMs at screening
- Has a body weight of less than 5 kg at screening
Part B:
- Participant has clinically relevant medical, neurologic, or psychiatric condition and/or behavioral disorder (including those related to GRIN-NDD) that would preclude or jeopardize participant's safe participation of study drug administration or the conduct of the study according to the judgement of the investigator or sponsor.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:三倍
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Radiprodil
Liquid suspension of radiprodil, at varying concentrations depending on participant's weight. The following dose-escalation regimen (twice daily [BID]) will be used: Titration Period Visit 1 (Visit T1): Dose 1, Visit T2: Dose 2, Visit T3: Dose 3, Visit T4: Maintenance Dose. |
Radiprodil oral suspension |
|
安慰剂比较:Placebo
Liquid suspension of placebo matching radiprodil oral suspension and dose-escalation regimen. |
Placebo-to-match radiprodil oral suspension |
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
A部分 - 第3阶段队列1(符合资格的癫痫发作队列):可计数的运动性癫痫发作(CMS)
大体时间:12周
|
12周
|
|
A部分 - 第3阶段队列2(无符合资格癫痫发作辅助队列):不良事件(AEs)、严重不良事件(SAEs)及药物不良反应(ADRs)
大体时间:24周
|
24周
|
|
B部分 - 开放标签扩展期:不良事件(AEs)、严重不良事件(SAEs)和药物不良反应(ADRs)
大体时间:平均两年
|
平均两年
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
A部分 - 第3阶段队列1(符合资格癫痫发作队列):CMS降低≥50%的参与者比例
大体时间:12周
|
12周
|
|
A部分 - 第3阶段队列1(符合条件癫痫发作队列):无CMS天数
大体时间:12周
|
12周
|
|
第A部分 - 第3阶段队列1(符合条件癫痫发作队列):GRIN-NDD特异性临床总体印象-变化[CGC-C]量表
大体时间:12周
|
12周
|
|
A部分 - 第3阶段队列1(符合条件癫痫发作队列):异常行为检查表-社区版(ABC-2C)易怒子量表
大体时间:12周
|
12周
|
|
部分A - 第3阶段队列1(符合条件癫痫发作队列):文兰适应行为量表第三版(VABS-3)日常生活个人子领域
大体时间:12周
|
12周
|
|
A部分 - 第3阶段队列2(无合格癫痫发作辅助队列):GRIN-CGI-C量表
大体时间:24周
|
24周
|
|
A部分 - 第3阶段队列2(无符合条件癫痫发作辅助队列):ABC-2C易怒子量表
大体时间:24周
|
24周
|
|
A部分 - 第3阶段第2队列(无符合条件癫痫发作辅助队列):VABS-3日常生活个人能力子领域
大体时间:24周
|
24周
|
|
B部分 - 开放标签扩展:CMS频率
大体时间:平均2年
|
平均2年
|
|
B部分 - 开放标签延长期:无CMS天数
大体时间:平均2年
|
平均2年
|
|
B部分 - 开放标签延伸期:ABC-2C易怒子量表
大体时间:平均2年
|
平均2年
|
|
B部分 - 开放标签延长期:VABS-3日常生活个人子领域评分
大体时间:平均2年
|
平均2年
|
|
B部分 - 开放标签扩展:GRIN-CGI-C量表
大体时间:平均2年
|
平均2年
|
合作者和调查者
调查人员
- 研究主任:Russell Chin、GRIN Therapeutics, Inc.
- 研究主任:Stephen Tisi、GRIN Therapeutics, Inc.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.